Mizuho’s Jared Holz talks Novo Nordisk falling on Alzheimer’s trial

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

Jared Holz, Mizuho, joins ‘Fast Money’ to talk Novo Nordisk shares sliding on latest drug trial and how to treat the stock at its current lows.